Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery — Stella

Recruiting

Back to Oesophageal Adenocarcinoma trials

Trial locations(1 site)

United Kingdom

Imperial College Healthcare NHS Trust, London

Key details

Sponsor

Imperial College London

Collaborators

Cancer Research UK

Enrollment target

~100 participants

Started

February 2025

Primary completion

June 2028

Age range

18 Years – 90 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov